In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f

Chronic kidney disease (CKD) is a life-threatening disease for many people. People suffering from such diseases need to undergo some form of kidney replacement therapy in order to live a long life. (1, 2) In 2019, it is estimated that 1.4 million people will die from chronic kidney disease worldwide

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack

A concept on social determinants of health and the Ottawa Charter’s action areas for health promotion have drawn, in many countries, awareness to the health impacts resulting from a public policy. In Thailand, the issue was taken under consideration in the process of the National Health Systems Refo

The evaluation of public health in Thailand is conducted via the National Health Examination Survey (NHES). This programme has been implemented since 1991 and serves as an important source of health data due to comprehensive and accurate medical examinations conducted by medical personnel – which ar

People with hearing loss who are registered under the Universal Health Coverage scheme areeligible to receive hearing aids from hospitals free-of-charge. However, the costs associated with this policy after having received the hearing aids must still be borne by users such as hearing aid maintenance

Health financing is a component of the health system, crucial in achieving universal health coverage (UHC). Careful design of its three main functions, resource mobilisation, pooling and allocation, ensures improved access to essential health services and financial risk protection for

Antimicrobial Resistance (AMR) occurs when pathogens (bacteria, viruses, fungi, and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR has been increasing in low-, middle- and high-income

Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted

AMR occurs when pathogens (bacteria, viruses, fungi and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR is a natural phenomenon, however the speed at which it occurs is impacted by how